Breast cancer is a biologically heterogeneous disease in which genomic complexity, dynamic tumor evolution, and variable therapeutic response continue to ...
Gastric cancer remains one of the leading causes of cancer-related mortality worldwide, primarily due to late-stage diagnosis ...
Clinical trial attrition can be detrimental to clinical outcomes, patient well-being and the financial health of research programs. Clinical trial dropout rates, which range from 15% to 40%, greatly ...
The most underestimated category, and the one with the most long-term potential, is clinical-driven AI, where the model is ...
The FDA real-time clinical trial model enables prospective safety monitoring, improving risk assessment and speeding oncology drug development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results